DocMorris AG

DocMorris AG

0RRB · LSE

18.84GBP-0.16 (-0.84%)

Price History

Full chart

Market Stats

Previous Close19.00
Open18.91
Day Range18.84 – 19.27
52-Week Range3.92 – 13.58
Volume16.42K
Market Cap60.78M
P/E (TTM)0.00
Forward P/E0.00
EPS-23.40
Dividend Yield0.00%
Beta1.88
50-Day Avg80.94
200-Day Avg58.41

About

DocMorris AG operates as an online pharmacy, telemedicine, and healthcare company in Switzerland and internationally. The company offers prescription and over-the-counter medicines, and consumer health products, as well as beauty and personal care products, nutritional supplements, painkillers, and first aid products. The company also provides professional health care services to doctors, pharmacies, insurers, and health institutions. It sells its products to online mail-order pharmacies, and private individuals under the DocMorris, PromoFarma by DocMorris, and TeleClinic brands. The company was formerly known as Zur Rose Group AG and changed its name to DocMorris AG in May 2023. DocMorris AG was founded in 1993 and is headquartered in Frauenfeld, Switzerland.

Company Details

Leadership

  • Mr. Walter OberhansliFounder & Chairman · b. 1958
  • Mr. Walter HessCEO & Member of Executive Board · b. 1965
  • Mr. Daniel WüestCFO & Member of Executive Board · b. 1970
  • Mr. David MasoChief AI Health Officer & Member of Executive Board · b. 1971
  • Mr. Kaspar NiklausCOO & Member of Executive Board · b. 1968
  • Mr. Pablo Ros GomezCTO & Member of Executive Board · b. 1982
  • Ms. Andrea SkersiesChief Commercial Officer & Member of the Executive Board · b. 1972
  • Dr. Daniel GrigatGroup Head of Investor Relations & Sustainability
  • Torben BonnkeDirector of Communications

Financials

Income Statement

Currency: GBP2010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue488.27M487.19M524.66M915.59M920.38M834.42M879.53M982.92M1.21B1.36B1.48B1.73B930.97M969.46M1.02B1.12B
Growth (%)--0.22%+7.69%+74.51%+0.52%-9.34%+5.41%+11.75%+22.81%+12.30%+8.96%+16.90%-46.08%+4.13%+4.91%+10.57%
Cost of Revenue416.05M415.72M477.46M832.68M833.71M769.26M816.42M926.19M1.13B1.29B1.42B1.66B924.12M766.11M945.99M1.02B
Gross Profit72.22M71.47M47.20M82.91M86.68M65.16M63.11M56.73M78.98M60.59M60.38M61.84M6.85M203.35M71.06M105.69M
Gross Margin14.79%14.67%9.00%9.06%9.42%7.81%7.18%5.77%6.54%4.47%4.09%3.58%0.74%20.98%6.99%9.40%
Operating Expense64.79M66.29M44.57M86.75M69.34M54.92M65.65M91.86M113.13M144.09M191.20M259.38M145.40M113.65M162.58M189.98M
Operating Income7.43M5.18M2.63M-3.84M17.34M10.23M-2.54M-35.13M-34.15M-83.51M-130.82M-197.54M-138.55M89.70M-91.52M-84.29M
Operating Margin1.52%1.06%0.50%-0.42%1.88%1.23%-0.29%-3.57%-2.83%-6.16%-8.86%-11.44%-14.88%9.25%-9.00%-7.50%
EBITDA12.89M9.94M5.47M-545.00K20.09M15.22M-409.00K-23.62M-18.05M-13.67M-76.13M-150.84M-109.79M-65.26M-37.02M-39.40M
EBITDA Margin2.64%2.04%1.04%-0.06%2.18%1.82%-0.05%-2.40%-1.50%-1.01%-5.15%-8.74%-11.79%-6.73%-3.64%-3.50%
Net Income3.92M8.67M6.14M-15.46M7.15M3.44M-12.77M-36.24M-38.97M-52.36M-135.69M-225.74M-170.30M82.28M-97.25M-134.40M
Net Income Margin0.80%1.78%1.17%-1.69%0.78%0.41%-1.45%-3.69%-3.23%-3.86%-9.19%-13.07%-18.29%8.49%-9.56%-11.95%
Interest Expense1.25M1.15M1.07M2.47M3.53M3.67M3.03M2.72M2.12M5.90M15.75M17.44M18.86M19.14M19.96M17.67M
Interest Expense % of Total Revenue0.26%0.24%0.20%0.27%0.38%0.44%0.34%0.28%0.18%0.44%1.07%1.01%2.03%1.97%1.96%1.57%

Balance Sheet

Currency: GBP2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets168.37M145.27M144.47M265.74M225.11M228.12M233.42M261.53M461.77M726.52M991.73M1.28B1.27B1.10B866.42M778.13M825.40M
Total Liabilities78.23M66.07M62.67M179.55M151.73M150.77M160.65M157.72M167.54M282.91M586.18M746.74M784.29M748.67M435.89M438.02M416.35M
Total Equity90.14M79.19M81.80M86.19M73.38M77.35M72.78M103.81M294.00M443.58M405.65M531.74M484.92M350.78M430.53M340.11M409.06M
Cash17.39M11.86M7.45M54.85M31.18M21.12M25.16M25.23M107.76M230.69M204.68M300.61M277.74M126.04M54.03M95.37M119.89M
Total Debt19.57M22.06M18.56M78.31M58.61M58.26M62.80M59.08M4.14M117.22M355.73M526.43M525.15M528.64M330.81M312.21M288.64M
Net Debt2.18M10.20M11.12M-54.85M27.42M37.14M37.64M33.85M-103.62M-113.47M151.04M225.82M247.41M402.59M276.79M216.84M168.74M

Cash Flow

Currency: CHF2010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow13.96M2.81M20.81M2.00M7.20M18.87M-13.83M-22.23M-33.23M-82.57M-67.51M-130.63M-97.29M-87.42M-26.48M-88.26M
Investing Cash Flow-5.29M127.00K-13.40M-11.09M-15.99M-16.40M-23.10M-62.22M-140.28M-143.18M-200.60M-67.33M-89.77M219.82M93.76M-52.47M
Financing Cash Flow-14.10M-7.21M40.03M-14.91M-1.05M2.50M37.03M165.91M297.06M200.19M363.99M179.72M39.11M-202.63M-26.00M165.83M
Capital Expenditure5.22M3.08M937.00K2.54M6.92M15.23M19.93M21.64M31.50M41.51M59.83M63.48M46.57M4.99M1.36M1.77M
Free Cash Flow8.74M-275.00K19.87M-536.00K284.00K3.65M-33.76M-43.87M-64.73M-124.08M-127.34M-194.11M-143.85M-92.40M-27.84M-90.03M
Dividends Paid5.70M3.77M1.51M1.51M-1.92M1.64M165.91M182.99M205.09M363.25M179.72M----
FCF to OCF62.61%-9.80%95.50%-26.75%3.94%19.31%244.09%197.36%194.81%150.27%188.62%148.59%147.87%105.71%105.14%102.01%
Dividend Paid to FCF65.18%-1371.64%7.59%-281.16%-52.70%-4.85%-378.21%-282.70%-165.29%-285.26%-92.59%----

Earnings

Report DateMar 31, 2025Aug 19, 2025Mar 18, 2027
EPS Estimate---
EPS Actual-1.05-1.18-
Surprise---
Timing-After-hoursAfter-hours

Key Statistics & Ratios

Market Cap60.78M
Enterprise Value813.84M
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.05
Price / Book0.00
EPS-23.40
Book Value7.41
Revenue (TTM)1.18B
Gross Profit (TTM)261.25M
EBITDA-75.61M
Profit Margin-10.65%
Operating Margin-6.83%
Return on Equity-30.05%
Return on Assets-6.37%
Shares Outstanding6.19M
Shares Float35.61M
Beta1.88
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • May 13, 2025593:292
  • Nov 22, 2018113:107